Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) CFO David Lunin purchased 2,500 shares of the stock in a transaction on Tuesday, March 4th. The stock was acquired at an average price of $13.05 per share, with a total value of $32,625.00. Following the acquisition, the chief financial officer now directly owns 2,500 shares in the company, valued at $32,625. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Calumet Specialty Products Partners Stock Performance
Calumet Specialty Products Partners stock opened at $12.98 on Thursday. The stock's 50 day moving average price is $17.83 and its 200 day moving average price is $19.20. The firm has a market capitalization of $1.12 billion, a PE ratio of -4.70 and a beta of 1.88. Calumet Specialty Products Partners, L.P. has a one year low of $9.97 and a one year high of $25.29.
Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings results on Friday, February 28th. The oil and gas company reported ($0.47) EPS for the quarter, topping the consensus estimate of ($1.06) by $0.59. The company had revenue of $949.50 million for the quarter, compared to analyst estimates of $921.76 million. The business's revenue was down 2.8% on a year-over-year basis. During the same period last year, the firm posted ($0.59) earnings per share. On average, analysts forecast that Calumet Specialty Products Partners, L.P. will post -3.02 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
Several research firms have commented on CLMT. TD Cowen cut Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and lowered their price target for the company from $26.00 to $16.00 in a report on Tuesday. StockNews.com upgraded Calumet Specialty Products Partners to a "sell" rating in a report on Monday, November 18th. HC Wainwright reiterated a "buy" rating and set a $33.00 target price on shares of Calumet Specialty Products Partners in a report on Monday. Wells Fargo & Company decreased their target price on Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating for the company in a report on Wednesday. Finally, UBS Group cut Calumet Specialty Products Partners from a "neutral" rating to a "sell" rating and decreased their target price for the stock from $20.50 to $15.00 in a report on Tuesday, February 4th. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $21.40.
Check Out Our Latest Research Report on Calumet Specialty Products Partners
Calumet Specialty Products Partners Company Profile
(
Get Free Report)
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
